Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?

Ann Rheum Dis. 2016 Jun;75(6):947-9. doi: 10.1136/annrheumdis-2015-208863. Epub 2016 Feb 9.

Authors

P Verschueren¹, R Westhovens¹

Affiliation

¹ Department of Development and Regeneration KU Leuven, Skeletal Biology and Engineering Research Center, Leuven, Belgium Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium.

PMID: 26861701
DOI: 10.1136/annrheumdis-2015-208863

No abstract available

Keywords: Outcomes research; Rheumatoid Arthritis; Treatment.

Publication types

Editorial
Comment

MeSH terms

Arthritis, Rheumatoid*
Denosumab*
Humans

Substances

Denosumab